TR-1: Standard form for notification of major holdings
PERTH, AUSTRALIA / ACCESSWIRE / June 21, 2023 /
ISIN
JE00B5TT1872 |
Issuer Name
Centamin PLC |
UK or Non-UK Issuer
UK |
2. Reason for Notification
An acquisition or disposal of voting rights |
3. Details of person subject to the notification obligation
Name
Van Eck Associates Corporation |
City of registered office(if applicable)
New York |
Country of registered office (if applicable)
United States |
4. Details of the shareholder
Name | City of registered office | Country of registered office |
VanEck Natural Resources ETF |
|
|
VanEck Global Mining UCITS ETF |
|
|
VanEck Africa ETF |
|
|
VanEck Egypt ETF |
|
|
VanEck Gold Miners ETF (AU) |
|
|
VanEck Junior Gold Miners UCITS ETF |
|
|
VanEck Gold Miners UCITS ETF |
|
|
VanEck Junior Gold Miners ETF |
|
|
VanEck Gold Miners ETF |
|
|
5. Date on which the threshold was crossed or reached
16-June-2023 |
6. Date on which Issuer notified
20-June-2023 |
7. Total positions of person(s) subject to the notification obligation
| % of voting rights attached to shares (total of 8.A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer |
Resulting situation on the date on which threshold was crossed or reached | 9.6048 | 0.00000 | 9.6048 | 1,158,432,960 |
Position of previous notification (if applicable) | 10.3295 | 0.00000 | 10.3295 | 1,156,450,695 |
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
JE00B5TT1872 | 111,264,960 |
| 9.6048 |
|
Sub Total 8.A | 111,264,960 | 9.6048% |
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
Sub Total 8.B1 |
|
|
|
Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |
Sub Total 8.B2 |
|
|
|
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary) |
Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
Van Eck Associates Corporation | VanEck Africa ETF | 0.043100 |
| 0.043100% |
Van Eck Associates Corporation | VanEck Egypt ETF | 0.045000 |
| 0.045000% |
Van Eck Associates Corporation | VanEck Gold Miners ETF | 5.327400 |
| 5.327400% |
Van Eck Associates Corporation | VanEck Junior Gold Miners ETF | 3.307200 |
| 3.307200% |
Van Eck Associates Corporation | VanEck Natural Resources ETF | 0.002000 |
| 0.002000% |
Van Eck Associates Corporation | VanEck Global Mining UCITS ETF | 0.050300 |
| 0.050300% |
Van Eck Associates Corporation | VanEck Gold Miners UCITS ETF | 0.35920 |
| 0.359200% |
Van Eck Associates Corporation | VanEck Junior Gold Miners UCITS ETF | 0.34230 |
| 0.34230% |
Van Eck Associates Corporation | VanEck Gold Miners ETF (AU) | 0.128200 |
| 0.128200% |
10 .In case of proxy voting
Name of the proxy holder
Glass Lewis |
In case of proxy voting
The number and % of voting rights held
111,264,960 shares and 9.6048% voting right |
The date until which the voting rights will be held
Open |
11. Additional Information
12. Date of Completion
20-June-2023 |
13. Place Of Completion
Tampa, FL, USA |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
SOURCE: Centamin PLC